← Open Payments lookup

GERMONE SOUTHALL: Open Payments

NPI 1710438163 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,071 in 50 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $726 · 2025 $1,071

Food & beverage: $1,071
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$222
Neurocrine BioSciences, Inc.7$154
Otsuka America Pharmaceutical, Inc.7$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$140
Vanda Pharmaceuticals Inc.5$117
Alkermes, Inc.5$107
Janssen Pharmaceuticals, Inc3$87
E.R. Squibb & Sons, L.L.C.2$59
Axsome Therapeutics, Inc.2$35

Products named: AUSTEDO XR, INGREZZA, CAPLYTA, FANAPT, ARISTADA, REXULTI, INVEGA SUSTENNA, COBENFY.

Industry payments across WA — which companies pay providers there.